FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080150 [Registered on: 07/02/2025] Trial Registered Prospectively
Last Modified On: 01/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Yoga & Naturopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A clinical trail to study the effect of electroacupuncture in altering the pain related disability in patients with migraine. 
Scientific Title of Study   Effect of electroacupuncture to GB44, TE21, ST36 and LR2 on pain and disability in migraineurs: A randomised placebo - controlled trial.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr N Sheeja Begum 
Designation  PG Scholar 
Affiliation  Government Yoga and Naturopathy Medical College and Hospital 
Address  Department of Acupuncture and Energy Medicine,Room No 2, Second floor, Govt Yoga and Naturopathy Medical College and Hospital PG Block, Arumbakkam, Chennai - 600106 Tamilnadu, India

Chennai
TAMIL NADU
600106
India 
Phone  9095760785  
Fax    
Email  sheejanazir13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr A Mooventhan 
Designation  Assistant Medical Officer cum Lecturer, Department of Research  
Affiliation  Government Yoga and Naturopathy Medical College and Hospital 
Address  Department of Research, Second floor, Room no 4, Govt Yoga and Naturopathy Medical College and Hospital PG Block, Arumbakkam, Chennai - 600106 Tamilnadu, India

Chennai
TAMIL NADU
600106
India 
Phone  9844457496  
Fax    
Email  dr.mooventhan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr N Sheeja Begum 
Designation  PG Scholar 
Affiliation  Government Yoga and Naturopathy Medical College and Hospital 
Address  Department of Acupuncture and Energy Medicine, Second floor,Room no 2, Govt Yoga and Naturopathy Medical College and Hospital PG Block, Arumbakkam, Chennai - 600106 Tamilnadu, India

Chennai
TAMIL NADU
600106
India 
Phone  9095760785  
Fax    
Email  sheejanazir13@gmail.com  
 
Source of Monetary or Material Support  
Government Yoga and Naturopathy Medical College and Hospital, Arumbakkam, Chennai, TamilNadu, India Pincode- 600106 
 
Primary Sponsor  
Name  Government Yoga and Naturopathy Medical College and Hospital 
Address  Government Yoga and Naturopathy Medical College and Hospital, Arumbakkam, Chennai - 600106 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr N Sheeja Begum  Government Yoga and Naturopathy Medical College and Hospital  2nd floor,Room no 2, Department of Acupuncture and Energy Medicine, Post graduate block, Arumbakkam, Chennai- 600106, Tamil Nadu
Chennai
TAMIL NADU 
9095760785

sheejanazir13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government Yoga and Naturopathy Medical College and Hospital, Chennai, Institutional Ethical Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G431||Migraine with aura, (2) ICD-10 Condition: G430||Migraine without aura,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Electrical stimulation at acupuncture points  Acupuncture needling with electrical stimulus will be given at four points GB44, TE21, ST36 and LR2 with 30 mins retention for 5 days a week for a total of 2 weeks. The stimulus will be of intermittent wave frequency of 5Hz and the intensity will be adjusted according to patients tolerance. 
Comparator Agent  Electrical stimulation at non-acupuncture points  Acupuncture needling will be given at 4 non-acupuncture points with electrical stimulus and 30 mins retention for 5 days a week for a total duration of 2 weeks. The stimulus will be of intermittent wave; frequency of 5Hz and the intensity will be adjusted according to patients tolerance. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1) Patients who confirm the diagnostic criteria for migraine stipulated by The International
Classification of Headache Disorders, 3rd edition
2) Patients of Migraine with aura (MwA) and Migraine without aura (MwoA)
3) Patients not under drugs for migraine prophylaxis
4) Patients willing to take part in research and give written informed consent  
 
ExclusionCriteria 
Details  1) Other primary and secondary types of headaches
2) Cerebral hemorrhage and vascular malformation
3) Stroke
4) Parkinson’s and other extrapyramidal diseases
5) History of epilepsy or any mental disorders
6) Intake of anti-psychotic or anti-depressant drugs
7) Neuralgia of face or head
8) Pregnancy, lactation or insufficient contraception
9) Immunodeficiency and bleeding disorders
10) Severe pain syndromes of cervical spine
11) Serious illness such as cancer
12) Patients with metal implants, pacemaker or prosthetics
13) Phobia to needling and electrical stimulation
14) Participation in any other clinical trial 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Migraine Disability Assessment (MIDAS) Questionnaire  Migraine Disability Assessment (MIDAS) Questionnaire will be measured before and after 2 weeks of intervention  
 
Secondary Outcome  
Outcome  TimePoints 
Electroencephalogram (EEG)  The changes in various frequency bands (alpha, beta, theta and delta) of cortical activity will be measured using EEG before and after 2 weeks of intervention  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A randomized placebo- controlled trial will be adopted for the study. 50 patients will be recruited from Government Yoga and Naturopathy Medical College and Hospital and randomly divided into study and control group. The baseline assessments such as Migraine disability assessment (MIDAS) questionnaire as a primary outcome measure and Electroencephalogram (EEG) as a secondary outcome measure will be recorded for both the groups. For study group electroacupuncture will be given to four acupuncture points (GB44, TE21, ST36 and LR2) and in control group electroacupuncture will be given at four non-acupuncture points. Electrical stimulus to acupuncture and non- acupuncture points will be given using acupoint nerve stimulator (ACS acupressure stimulator TENS – 2 channel) with intermittent  wave, frequency of 5Hz, current intensity adjusted according to patients’ tolerance with needle retention for 30 mins for 5 days per week for a total duration of 2 weeks. Post assessment will be taken after 2 weeks of intervention. 
Close